Request for Quotation for Procurement of Chemotherapy Drugs under Cancer Care and Pallative Care Medicine Access Program (CSPMAP) Line Item, etc. per PR no. 2720DS Request for Quotation (RFQ)   Reference Number 11397370   Procuring Entity EASTERN VISAYAS MEDICAL CENTER - DOH   Title Request for Quotation for Procurement of Chemotherapy Drugs under Cancer Care and Pallative Care Medicine Access Program (CSPMAP) Line Item, etc. per PR no. 2720DS   Area of Delivery Leyte   Printable Version Solicitation Number: 2720DS Trade Agreement: Implementing Rules and Regulations Procurement Mode: Negotiated Procurement - Small Value Procurement (Sec. 53.9) Classification: Goods Category: Drugs and Medicines Approved Budget for the Contract: PHP 277,600.00 Delivery Period: 60 Day/s Client Agency: Contact Person: JOSEPH ARIES B. BERNARDO Administrative Officer V , Procurement Department Brgy. 93 Bagacay, Tacloban, City Tacloban City Leyte Philippines 6500 63-053-8325309 evrmc.bacsec@gmail.com Status Active Associated Components Order Bid Supplements 0 Document Request List 0 Date Published 24/10/2024 Last Updated / Time 24/10/2024 12:00 AM Closing Date / Time 28/10/2024 1:00 PM Description Republic of the Philippines Department of Health Center for Health Development EASTERN VISAYAS MEDICAL CENTER Tacloban City REQUEST FOR QUOTATION RFQ No: 2024-10-SVP-0327 October 21, 2024 The EVMC, Tacloban City, through the Bids & Awards Committee, invites suppliers/manufacturer/distributors/contractors to submit quotation and to quote for the hereunder list of procurement: PR No. Name of Project/Location ABC Duration 2720DS Procurement of Chemotherapy Drugs under Cancer Care and Pallative Care Medicine Access Program (CSPMAP) Line Item Methotrexate 2.5 mg Methotrexate (as sodium salt) 25 mg/mL, 2 mL preservative-free (IM, IV, Intrathecal) Terms and Conditions: *Follow indicated specifications Delivery / Payment Schedule: * Delivery shall be made per delivery schedule: every two (2) months and/or staggard basis as maybe required by EVMC as provided for under Annex D of RA 9184 on Amendment to Order. * If supplier fails to deliver within the agreed timeline, it shall be liable for liquidated equivalent to 1/10th of 1% of the undelivered item’s worth multiplied by the number of days delayed. Once the cumulative amount of liquidated damages reaches 10% of the total amount of the items ordered the procuring entity may cancel the Purchase Order * Supplier must submit Sales Invoice together with the request for payment every after delivery. PAYMENT TERMS: * Payment shall be made within 60 days from the completion of all deliveries per line in the Purchase Order and upon submission and completion of all documentary requirements. Other Requirements: 1. Valid and current Certificate of Product Registration (CPR) issued by the FDA. IF CPR is expired, certified true copy of Official receipt and tracking document from FDA 2. License To Operate for drug suppliers, distributors and traders issued by the FDA as per RA 9711 (FDA Act of 2009) and its IRR and DOH AO No. 2016-003. Requirement for Inspection and Delivery: 1. Shelf life should be not less than 18 months at the time of delivery. Supplier should specify the date of expiration and should be willing to replace unconsumed drugs and medicines at least three (3) months prior to expiry date. 2. Cold chain should be observed in the transport of temperature-sensitive drugs and medicines. They should be delivered to the Materials Management Department (MMD) in tightly sealed containers packed with cooling devices. Deliveries not within the required temperature shall be returned to the supplier immediately upon verification at the MMD. 3. Upon delivery, drugs and medicines with physical signs of degradation such as discoloration of tablets, capsules, solutions and powder for reconstitution, chips, cracks in tablets, crushed capsules, caking in suspensions and moisture droplets in vials of dry powder shall be returned to and replaced by the supplier at no additional cost to the hospital, Likewise, drugs and medicines with packaging that have signs of damage or deterioration shall be returned to the supplier. 4. Deliveries may be subjected to test analysis by the FDA. Quantities subjected for test analysis should be replaced and the payment/processing fee should be paid by the winning bidder. In case of failure of test analysis, award of the said item shall be cancelled and procurement shall be made to the next lowest complying bidder. 5. Each item should be labelled in accordance with the provisions of DOH Administrative Order No. 2016-0008 dated 21 March 2016. ABC : Php277,600.00 Dept./Unit/Section: PHARMACY / F.AMARGA RPH Mode of Procurement: Negotiated Procurement – Small Value Procurement The complete schedule of activities is listed, as follows: Activities Schedule 1. Posting Period at PhilGEPS Oct 24, 2024 –Oct 28, 2024 2. Issuance of RFQ Oct 24, 2024 –Oct 28, 2024 3. Pre-Bid Conference - N/A 4. Submission and Receipt of RFQ Oct 28, 2024, 01:00 P.M. 5. Opening of RFQ Oct 28, 2024, 01:00 P.M, @ BAC Office The Eastern Visayas Medical Center assumes no responsibility whatsoever to compensate or indemnify bidders for any expenses incurred in the preparation of the bid. DR. MARION A. ACUIN, FPSO-HNS Chairman, Bids & Awards Committee (BAC-A) Created by JOSEPH ARIES B. BERNARDO Date Created 23/10/2024 The PhilGEPS team is not responsible for any typographical errors or misinformation presented in the system. PhilGEPS only displays information provided for by its clients, and any queries regarding the postings should be directed to the contact person/s of the concerned party.       EASTERN VISAYAS MEDICAL CENTER - DOH